{"id":500711,"date":"2021-06-03T16:34:14","date_gmt":"2021-06-03T20:34:14","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\/"},"modified":"2021-06-03T16:34:14","modified_gmt":"2021-06-03T20:34:14","slug":"sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\/","title":{"rendered":"Sarepta Therapeutics to Present at Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">CAMBRIDGE, Mass., June  03, 2021  (GLOBE NEWSWIRE) &#8212; Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in fireside chats at two upcoming virtual investor conferences:<\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">Goldman Sachs 42nd Annual Global Healthcare Conference on Thursday, June 10 at 1:20 p.m. E.T.<\/li>\n<li style=\"text-align:justify\">BofA Securities 2021 Napa BioPharma Virtual Conference on Wednesday, June 16 at 10:30 a.m. E.T.<\/li>\n<\/ul>\n<p align=\"justify\">The presentations will be webcast live under the investor relations section of Sarepta\u2019s website at <u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=N8lq2MWhzHyHs0j0RBc-ctSs0-F10Rpj7kWLa9dXumAhAum1Se6vEchgDPTqQ5zR4wE2n3JkelgsEaP96-SJCg==\" rel=\"nofollow noopener\" target=\"_blank\">www.sarepta.com<\/a><\/u>\u00a0and will be archived there following the presentation for 90 days. Please connect to Sarepta&#8217;s website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <em>About Sarepta Therapeutics<\/em><br \/>\n        <\/strong><br \/>\n        <br \/>Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=N8lq2MWhzHyHs0j0RBc-ci-dIFnyfQg0jLbi1kw4yjKiGIiOa1AcnSoX5-Frb7bSykHurY5GfQFIF6QmGzm9VA==\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.sarepta.com<\/u><\/a> or follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=G1VlKNxonocWNmcIQhn1ueeCXdcihb4MANI_n-e58lG0A6N-3JOFdV4s6TIyzYlGXuM467m3VuYos3zS2TQuWg==\" rel=\"nofollow noopener\" target=\"_blank\"><u>Twitter<\/u><\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WvT95_ukZ8sO1eWaHV447B_vHq28_VCfFaeCX0PDmqZgsDuxv4vv1TAAm8BPP99kFF1mQDubdszxfH9HBKYUxFiFBKMoUdS22lgy2uXlglIvHFYx-ZUwJj8Ru6ezGjdG\" rel=\"nofollow noopener\" target=\"_blank\"><u>LinkedIn<\/u><\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nCtMalvswDW0LTbXOIQPcqDpO4Q5FzI9n77ZOp3sSplOF4Sdx2iPb6H2cO3VH867_BdvcG8aWO9m37dOjL0RdjEt9RbtMhdK5sHEA-XEgmc=\" rel=\"nofollow noopener\" target=\"_blank\"><u>Instagram<\/u><\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=joQkypmAEqYVuNq_lAMLLEbD4H7q4T3dzyzejAyv59yvqmIePT6NPaT5ELOWSKEp9Lo4LJMEpg_d6t9COj5_oM64X1H38E0KVDXIlCy8jnH8zKyoXt9VsNMjY-0bHcAy\" rel=\"nofollow noopener\" target=\"_blank\"><u>Facebook<\/u><\/a>.<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <em>Internet Posting of Information<\/em><br \/>\n        <\/strong><br \/>\n        <br \/>\n        <em>We routinely post information that may be important to investors in the &#8216;For Investors&#8217; section of our website at\u00a0<\/em><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=N8lq2MWhzHyHs0j0RBc-cj_y0Ivx84GlUQpKdkjU3gM_asvMTQeskqgTe-q7BgFdMPyUYcn26k0v9tP_hXsoXQ==\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n          <em><br \/>\n            <u>www.sarepta.com<\/u><br \/>\n          <\/em><br \/>\n        <\/a><br \/>\n        <em>. We encourage investors and potential investors to consult our website regularly for important information about us.<\/em>\n      <\/p>\n<p>Source: Sarepta Therapeutics, Inc.<\/p>\n<p>\n        <strong><br \/>\n          <em>Investor Contact: <\/em><br \/>\n        <\/strong><br \/>\n        <br \/>Ian Estepan, 617-274-4052<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mEfjGK7ys-BR52GH9pMLXTufWfEdwjUkbaPiRUsE_9wtP3ouaBTjXdjvti-9gKLSAtef15f0JIdzqmX7S_nZZqHY3E2h4YXqTYq9mN_KfGc=\" rel=\"nofollow noopener\" target=\"_blank\"><u>iestepan@sarepta.com<\/u><\/a><\/p>\n<p>\n        <strong><br \/>\n          <em>Media Contact: <\/em><br \/>\n        <\/strong><br \/>\n        <br \/>Tracy Sorrentino, 617-301-8566<br \/><u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3sNgq7WeuZdVI0b2fVz713wogGCPHx3aI63SQlF8_wjHPF1PDemTHM1hMqMc2NXcQJjXjl4FpmbfJq581_b4YyuRXRRucQJ72-G6FFJB9Rk=\" rel=\"nofollow noopener\" target=\"_blank\">tsorrentino@sarepta.com<\/a><\/u><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0ODU1MiM0MjI2ODQ2IzIwMDcxNTc=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/af18b571-a190-4d53-b456-2b87f55d6a1a\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass., June 03, 2021 (GLOBE NEWSWIRE) &#8212; Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in fireside chats at two upcoming virtual investor conferences: Goldman Sachs 42nd Annual Global Healthcare Conference on Thursday, June 10 at 1:20 p.m. E.T. BofA Securities 2021 Napa BioPharma Virtual Conference on Wednesday, June 16 at 10:30 a.m. E.T. The presentations will be webcast live under the investor relations section of Sarepta\u2019s website at www.sarepta.com\u00a0and will be archived there following the presentation for 90 days. Please connect to Sarepta&#8217;s website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary. About &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Sarepta Therapeutics to Present at Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-500711","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sarepta Therapeutics to Present at Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sarepta Therapeutics to Present at Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass., June 03, 2021 (GLOBE NEWSWIRE) &#8212; Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in fireside chats at two upcoming virtual investor conferences: Goldman Sachs 42nd Annual Global Healthcare Conference on Thursday, June 10 at 1:20 p.m. E.T. BofA Securities 2021 Napa BioPharma Virtual Conference on Wednesday, June 16 at 10:30 a.m. E.T. The presentations will be webcast live under the investor relations section of Sarepta\u2019s website at www.sarepta.com\u00a0and will be archived there following the presentation for 90 days. Please connect to Sarepta&#8217;s website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary. About &hellip; Continue reading &quot;Sarepta Therapeutics to Present at Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-03T20:34:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0ODU1MiM0MjI2ODQ2IzIwMDcxNTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Sarepta Therapeutics to Present at Upcoming Investor Conferences\",\"datePublished\":\"2021-06-03T20:34:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\\\/\"},\"wordCount\":277,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI0ODU1MiM0MjI2ODQ2IzIwMDcxNTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\\\/\",\"name\":\"Sarepta Therapeutics to Present at Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI0ODU1MiM0MjI2ODQ2IzIwMDcxNTc=\",\"datePublished\":\"2021-06-03T20:34:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI0ODU1MiM0MjI2ODQ2IzIwMDcxNTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI0ODU1MiM0MjI2ODQ2IzIwMDcxNTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sarepta Therapeutics to Present at Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sarepta Therapeutics to Present at Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\/","og_locale":"en_US","og_type":"article","og_title":"Sarepta Therapeutics to Present at Upcoming Investor Conferences - Market Newsdesk","og_description":"CAMBRIDGE, Mass., June 03, 2021 (GLOBE NEWSWIRE) &#8212; Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in fireside chats at two upcoming virtual investor conferences: Goldman Sachs 42nd Annual Global Healthcare Conference on Thursday, June 10 at 1:20 p.m. E.T. BofA Securities 2021 Napa BioPharma Virtual Conference on Wednesday, June 16 at 10:30 a.m. E.T. The presentations will be webcast live under the investor relations section of Sarepta\u2019s website at www.sarepta.com\u00a0and will be archived there following the presentation for 90 days. Please connect to Sarepta&#8217;s website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary. About &hellip; Continue reading \"Sarepta Therapeutics to Present at Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\/","og_site_name":"Market Newsdesk","article_published_time":"2021-06-03T20:34:14+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0ODU1MiM0MjI2ODQ2IzIwMDcxNTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Sarepta Therapeutics to Present at Upcoming Investor Conferences","datePublished":"2021-06-03T20:34:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\/"},"wordCount":277,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0ODU1MiM0MjI2ODQ2IzIwMDcxNTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\/","name":"Sarepta Therapeutics to Present at Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0ODU1MiM0MjI2ODQ2IzIwMDcxNTc=","datePublished":"2021-06-03T20:34:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0ODU1MiM0MjI2ODQ2IzIwMDcxNTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0ODU1MiM0MjI2ODQ2IzIwMDcxNTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-present-at-upcoming-investor-conferences-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Sarepta Therapeutics to Present at Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/500711","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=500711"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/500711\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=500711"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=500711"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=500711"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}